FDAThu Sep 24, 2026
In the five trading days before ACAD's news on Sep 24 (Top-line results: Remlifanserin), traders put $242K into large options bets, about 6× ACAD's normal pace, mostly calls, which pay off if the stock rises. Foreshadow rates that unusual: 55 out of 100. Options were pricing in a move of about 18.5%. The stock fell 12.8%, against the bets, so they were wrong.
That betting was busier than 99% of 587 finished FDA cases.
The line is the stock price. Under it is each measurement that goes into the score. The yellow days are the five that count; the faded ones show what's normal for this stock. The number at the right of each row is how many of the 100 points it added.
Watch the betting build up, one trading day at a time.
Hover over a day to see its numbers, or select the chart and use the arrow keys.
A normal day for this stock, over the 60 days before, saw about $22K in large options bets.
20 large options trades were flagged in these five days, worth $674K in total. $242K of it was bought at the asking price; those are the bets. The rest was sold or traded between the two prices. A call pays off if the stock rises above its price; a put pays off if it falls below.
| Trade | Strike, expiry | Day | Amount |
|---|---|---|---|
| Callsold | $29, Oct 16 '26Wed Sep 23 | Wed Sep 23 | $99K |
| Callsold | $37, Oct 16 '26Fri Sep 18 | Fri Sep 18 | $79K |
| Callbought | $35, Oct 16 '26Fri Sep 18 | Fri Sep 18 | $60K |
Of 5 finished FDA cases that scored 39 to 71 with bets leaning toward a rise, the bets were right in 1 (20%), and the stock at least moved the way they leaned in 2 (40%).
| $28, Oct 16 '26Fri Sep 18 |
| Fri Sep 18 |
| $58K |
| Callsold | $28, Oct 16 '26Fri Sep 18 | Fri Sep 18 | $53K |
| Callbought | $35, Oct 16 '26Fri Sep 18 | Fri Sep 18 | $46K |
| Callbought | $28, Oct 16 '26Fri Sep 18 | Fri Sep 18 | $37K |
| Callbought | $25, Oct 16 '26Wed Sep 23 | Wed Sep 23 | $36K |
| Callsold | $28, Oct 16 '26Fri Sep 18 | Fri Sep 18 | $25K |
| Callbought | $35, Oct 16 '26Fri Sep 18 | Fri Sep 18 | $24K |
These are the 10 largest of 20, a sample from Unusual Whales data. The full list lives on Unusual Whales.
Each measurement is compared with this stock's normal 60 days. The further above normal, the more points it earns, up to its maximum. The points add up to the score. For the formula, see How it works.
How much was bet
$135K/day vs $22K normally, 4 vs 0.5 alerts/day, 0% sweeps
+16.4 of 25
How one-sided the bets were
net ask-side +$48K/day vs +$8K, calls $674K, puts $0
+8.2 of 20
New contracts opened
10,353 contracts/day vs 560, calls +21,779, puts +29,676
+11.0 of 20
Options volume vs. normal
92th percentile on average, peak 100, baseline 63
+13.8 of 15
Change in the cost of protection
put−call IV 11.1 → -19.8 pts, typical 5-day move ±17.2
+4.9 of 10
Big off-exchange stock trades
$648K/day in prints ≥ $1M vs $1.10M, 3 prints
+0.5 of 10
Built from seven kinds of Unusual Whales data for ACAD: large options trades (flow alerts), new open interest, options volume, the put and call price gap (skew), dark-pool prints, daily prices and the expected move. What each one measures
Short answers from this case's data and Unusual Whales, written by Claude.